Back

Tocilizumab is associated with a lower incidence of major adverse cardiovascular events in Giant Cell Arteritis

29 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Intersecting inflammation: cardiovascular disease across systemic condition Autoimmune/Chronic Inflammatory Disorders and Heart Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Alexis F Guedon

Hospital Saint-Antoine, Paris (France)

6 More presentations in this session

Presentation thumbnail
Neutrophil-to-lymphocyte ratio independently predicts short- and long-term adverse outcomes in cardiac sarcoidosis
Doctor E. Bobbio (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Immunoregulatory cytokine profile in ischemic heart disease: association of IL-35, IL-17A and FOXP3 with clinical severity
Professor R. Alshehristani (Karbala, IQ)
Abstract Slides Video
Presentation thumbnail
Data driven machine learning model for long-term mortality prediction in Takayasu Arteritis
Doctor A. Kante (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Stress CMR phenotyping across systemic diseases: ischemic burden and prognostic implications of late gadolinium enhancement
Doctor A. Kante (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Clinical course of pregnancies in patients with cardiac sarcoidosis
Doctor V. Rossi (Zurich, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Intersecting inflammation: cardiovascular disease across systemic condition

The Event

Event poster

ESC Congress 2026

29 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Session
Inflammation: a new target in cardiovascular disease prevention
29 August 2022
thumbnail
Congress Presentation
Initial experience with tocilizumab in patients with chronic refractory antibody-mediated rejection: a single center study.
19 May 2025
thumbnail
Congress Presentation
The potential effects of methotrexate on cardiovascular outcomes in rheumatoid arthritis patients: a multi-institutional analysis
31 August 2024
thumbnail
Congress Presentation
Imaging-guided lipid-lowering therapy in rheumatology patients at cardiovascular risk
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources